Download 01.04.14 - irishhealth.com - Bowel bug link to cancer progression

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Cancer immunotherapy wikipedia , lookup

Hospital-acquired infection wikipedia , lookup

Infection control wikipedia , lookup

Multiple sclerosis signs and symptoms wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Transcript
www.irishhealth.com
(http://www.irishhealth.com/article.html?id=23437)
Bowel bug link to cancer progression
[Posted: Tue 01/04/2014 by Niall Hunter, Editor www.irishhealth.com]
New evidence that a common gut bug is involved in bowel cancer has been uncovered by
researchers at the Royal College of Surgeons in Ireland (RCSI)
Researchers from the Department of Physiology and Medical Physics in RCSI found a
significantly increased presence of a common microbe Fusobacterium nucleatum (Fn) in
tissue and stool samples of patients with colorectal cancers and colorectal benign tumours.
Additionally, Fn infection levels were related to benign tumours progressing from early to
advanced stages and in the transition from a benign tumour to cancer.
Leader of the research project, Dr David Hughes, said the research found that cancer
patients with low bacterial levels had significantly longer survival times than patients with
moderate and high levels of the bacterium.
"Also, for patients with a benign tumour, we found that the presence of Fn may be a risk
factor for disease progression from tumour to cancer."
Dr Hughes said this was a significant finding as it highlighted the potential of Fn detection as
a possible indicator of colorectal cancers."
The research indicates that screening for Fn levels may be used as a new bowel cancer
detection method.
Targeted efforts to combat Fn infection could in future be considered for colorectal cancers
patients with high levels of the bacterium, in order to improve survival prospects, the
researchers believe.
Dr Hughes said: "Potentially, any impact of Fn infection on benign tumour development and
progression to more serious stages will be considerable, because 95% of all bowel cancers
arise from benign tumours, but only a small number of them become cancerous."
"Currently, there are no reliable predictive markers of whether a benign tumour will advance
to cancer."
The study, funded by the Health Research Board, is published in The European Journal of
Clinical Microbiology & Infectious Diseases.